Dean S, Kendall M J
Eur J Clin Pharmacol. 1983;24(1):1-5. doi: 10.1007/BF00613919.
Nifedipine has been assessed as a possible alternative to other third line drugs in the management of patients with difficult to control hypertension. A group of 20 patients whose blood pressure was unsatisfactory on a 3 drug regimen had their third drug stopped and after a 2 week period nifedipine was added to their beta-blocker plus diuretic therapy. Eleven became normotensive on 30 mg nifedipine daily and a further 6 on 60 mg daily; giving on overall success rate of 85%. This result was achieved with a reduction in side effects and an absence of any haemodynamic or metabolic complications.
硝苯地平已被评估为治疗难治性高血压患者时其他三线药物的一种可能替代药物。一组20例患者在三联药物治疗方案下血压控制不佳,停用第三种药物,2周后在其β受体阻滞剂加利尿剂治疗基础上加用硝苯地平。11例患者每日服用30毫克硝苯地平后血压恢复正常,另有6例每日服用60毫克硝苯地平后血压恢复正常;总体成功率为85%。这一结果是在副作用减少且无任何血流动力学或代谢并发症的情况下取得的。